Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates blue light photouncaging of a mu-opioid receptor agonist in the mouse brain, indicating a new optical probe for manipulating opioid signaling in vivo.
Here we report blue light-driven in vivo photoactivation of TCA-DCCM-DAMGO, a caged derivative of the μ-opioid receptor (MOR) agonist DAMGO. TCA-DCCM-DAMGO is chemically stable in the dark, is inactive prior to illumination, and cleanly liberates DAMGO upon irradiation with blue light. Brain slice electrophysiology demonstrates rapid, light-triggered MOR activation. Following intracerebroventricular infusion of TCA-DCCM-DAMGO in the mouse brain, photoactivation in the ventral tegmental area with blue light elicited a rapid, opioid-dependent increase in locomotion. These results demonstrate the feasibility of in vivo photouncaging using blue light deep in the mouse brain and establish TCA-DCCM-DAMGO as a probe for manipulating endogenous opioid receptors in behaving animals.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: